Cite
HARVARD Citation
Shiseki, M. et al. (2021). High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage. Leukemia & lymphoma. 62 (10), pp. 2448-2456. [Online].